Ansell Ltd
ASX:ANN
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Ansell Ltd
Interest Expense
Ansell Ltd
Interest Expense Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Interest Expense | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
Ansell Ltd
ASX:ANN
|
Interest Expense
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Nanosonics Ltd
ASX:NAN
|
Interest Expense
AU$340k
|
CAGR 3-Years
N/A
|
CAGR 5-Years
0%
|
CAGR 10-Years
-6%
|
|
|
Polynovo Ltd
ASX:PNV
|
Interest Expense
AU$918k
|
CAGR 3-Years
13%
|
CAGR 5-Years
55%
|
CAGR 10-Years
N/A
|
|
|
SDI Ltd
ASX:SDI
|
Interest Expense
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Anteris Technologies Ltd
ASX:AVR
|
Interest Expense
AU$70k
|
CAGR 3-Years
3%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
L
|
Lumos Diagnostics Holdings Ltd
ASX:LDX
|
Interest Expense
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Ansell Ltd
Glance View
Ansell Ltd, with its origins tracing back to the innovative entrepreneurship of founder Eric Norman Ansell in the early 20th century, has established itself as a global leader in protection solutions. Initially starting with condoms and expanding into gloves, the company now boasts a diversified portfolio encompassing protective solutions for industrial workers and healthcare professionals. This growth reflects Ansell's adept ability to identify and respond to evolving market demands. The company has capitalized on its deep expertise in material science and product design, underpinning its operations with a robust research and development framework that continually pushes the boundaries of product efficacy and safety. Instrumental to its business model is Ansell’s alignment with regulatory standards across its wide geographical footprint, ensuring that its products not only meet but often exceed industry and safety specifications. By navigating complex regulations and maintaining high standards, Ansell has cemented relationships with a broad clientele base drawn from healthcare providers, industrial entities, and retail channels. The company thrives by leveraging its extensive distribution network and strategic acquisitions, enhancing its global presence. Through innovative product lines, such as cut-protection gloves and surgical solutions, Ansell generates revenue by addressing critical safety needs, ensuring that both individuals and organizations can rely on its products to protect them in the most demanding environments.